A detailed history of Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. holds 471,736 shares of JANX stock, worth $22.6 Million. This represents 2.97% of its overall portfolio holdings.

Number of Shares
471,736
Holding current value
$22.6 Million
% of portfolio
2.97%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$35.29 - $50.26 $16.6 Million - $23.7 Million
471,736 New
471,736 $21.4 Billion

Others Institutions Holding JANX

About Janux Therapeutics, Inc.


  • Ticker JANX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,663,000
  • Market Cap $2B
  • Description
  • Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...
More about JANX
Track This Portfolio

Track Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. Portfolio

Follow Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A., based on Form 13F filings with the SEC.

News

Stay updated on Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. with notifications on news.